Marin Marie-France, Lonak Sylwia Fowler, Milad Mohammed R
Department of Psychiatry, Massachusetts General Hospital, 149 13th Street, Charlestown, MA, 02129, USA.
Curr Psychiatry Rep. 2015 Jun;17(6):39. doi: 10.1007/s11920-015-0582-0.
Exposure-based therapy has proven to be useful to treat various anxiety disorders as well as post-traumatic stress disorder (PTSD). Despite its efficacy, a fair proportion of patients remain symptomatic after treatment. Different lines of research have put considerable efforts to investigate ways to enhance the efficacy of exposure-based therapy, which could ultimately lead to better clinical outcomes for patients. Given that this type of therapy relies on extinction learning principles, neuroscience research has tested different adjuncts that could be used as cognitive enhancers through their impact on extinction learning and its consolidation. The current review will summarize some of the latest compounds that have received attention and show some promise to be used in clinical settings to improve the efficacy of exposure-based therapy.
基于暴露的疗法已被证明对治疗各种焦虑症以及创伤后应激障碍(PTSD)有用。尽管其疗效显著,但仍有相当一部分患者在治疗后仍有症状。不同的研究方向已投入大量精力来研究提高基于暴露的疗法疗效的方法,这最终可能为患者带来更好的临床结果。鉴于这类疗法依赖于消退学习原理,神经科学研究已测试了不同的辅助手段,这些手段可通过对消退学习及其巩固的影响用作认知增强剂。本综述将总结一些受到关注且有望用于临床环境以提高基于暴露的疗法疗效的最新化合物。